These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 16759167)

  • 1. Interferon regulatory factor-5-regulated pathways as a target for colorectal cancer therapeutics.
    Hu G; Barnes BJ
    Expert Rev Anticancer Ther; 2006 May; 6(5):775-84. PubMed ID: 16759167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting signal transduction pathways in colorectal cancer--more than skin deep.
    Cohen SJ; Cohen RB; Meropol NJ
    J Clin Oncol; 2005 Aug; 23(23):5374-85. PubMed ID: 15998904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apoptosis and colorectal cancer: implications for therapy.
    Yang SY; Sales KM; Fuller B; Seifalian AM; Winslet MC
    Trends Mol Med; 2009 May; 15(5):225-33. PubMed ID: 19362056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting apoptosis as an approach for gastrointestinal cancer therapy.
    Qiao L; Wong BC
    Drug Resist Updat; 2009 Jun; 12(3):55-64. PubMed ID: 19278896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Harnessing apoptosis for improved anticancer gene therapy.
    Waxman DJ; Schwartz PS
    Cancer Res; 2003 Dec; 63(24):8563-72. PubMed ID: 14695163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of MEK sensitizes paclitaxel-induced apoptosis of human colorectal cancer cells by downregulation of GRP78.
    Mhaidat NM; Alali FQ; Matalqah SM; Matalka II; Jaradat SA; Al-Sawalha NA; Thorne RF
    Anticancer Drugs; 2009 Aug; 20(7):601-6. PubMed ID: 19521235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inducible resistance of tumor cells to tumor necrosis factor-related apoptosis-inducing ligand receptor 2-mediated apoptosis by generation of a blockade at the death domain function.
    Li Y; Wang H; Wang Z; Makhija S; Buchsbaum D; LoBuglio A; Kimberly R; Zhou T
    Cancer Res; 2006 Sep; 66(17):8520-8. PubMed ID: 16951164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Putative chemosensitivity predictive genes in colorectal cancer cell lines for anticancer agents.
    Jung JJ; Jeung HC; Lee JO; Kim TS; Chung HC; Rha SY
    Oncol Rep; 2007 Sep; 18(3):593-9. PubMed ID: 17671706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Wnt signaling and cancer development: therapeutic implication.
    Paul S; Dey A
    Neoplasma; 2008; 55(3):165-76. PubMed ID: 18348648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modification of gene products involved in resistance to apoptosis in metastatic colon cancer cells: roles of Fas, Apaf-1, NFkappaB, IAPs, Smac/DIABLO, and AIF.
    Huerta S; Heinzerling JH; Anguiano-Hernandez YM; Huerta-Yepez S; Lin J; Chen D; Bonavida B; Livingston EH
    J Surg Res; 2007 Sep; 142(1):184-94. PubMed ID: 17603079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein kinase G as a therapeutic target for the treatment of metastatic colorectal cancer.
    Browning DD
    Expert Opin Ther Targets; 2008 Mar; 12(3):367-76. PubMed ID: 18269345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bypassing cancer drug resistance by activating multiple death pathways--a proposal from the study of circumventing cancer drug resistance by induction of necroptosis.
    Hu X; Xuan Y
    Cancer Lett; 2008 Feb; 259(2):127-37. PubMed ID: 18082322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. OPG is regulated by beta-catenin and mediates resistance to TRAIL-induced apoptosis in colon cancer.
    De Toni EN; Thieme SE; Herbst A; Behrens A; Stieber P; Jung A; Blum H; Göke B; Kolligs FT
    Clin Cancer Res; 2008 Aug; 14(15):4713-8. PubMed ID: 18676739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular biology of colorectal cancer: new targets.
    Kitisin K; Mishra L
    Semin Oncol; 2006 Dec; 33(6 Suppl 11):S14-23. PubMed ID: 17178280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apoptotic blocks and chemotherapy resistance: strategies to identify Bcl-2 protein signatures.
    Gul O; Basaga H; Kutuk O
    Brief Funct Genomic Proteomic; 2008 Jan; 7(1):27-34. PubMed ID: 18283052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autophagy signaling in cancer and its potential as novel target to improve anticancer therapy.
    Moretti L; Yang ES; Kim KW; Lu B
    Drug Resist Updat; 2007; 10(4-5):135-43. PubMed ID: 17627865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interferon regulatory factor-1-induced apoptosis mediated by a ligand-independent fas-associated death domain pathway in breast cancer cells.
    Stang MT; Armstrong MJ; Watson GA; Sung KY; Liu Y; Ren B; Yim JH
    Oncogene; 2007 Sep; 26(44):6420-30. PubMed ID: 17452973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overview how adenocarcinoma cancer cells avoid immune- and chemotherapy-induced apoptosis.
    Pajak B; Orzechowski A
    Adv Med Sci; 2006; 51():39-45. PubMed ID: 17357275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surviving cell death through epidermal growth factor (EGF) signal transduction pathways: implications for cancer therapy.
    Henson ES; Gibson SB
    Cell Signal; 2006 Dec; 18(12):2089-97. PubMed ID: 16815674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Understanding the predictive role of K-ras for epidermal growth factor receptor-targeted therapies in colorectal cancer.
    Ramos FJ; Macarulla T; Capdevila J; Elez E; Tabernero J
    Clin Colorectal Cancer; 2008 Dec; 7 Suppl 2():S52-7. PubMed ID: 19064407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.